Author:
Durán-Rosal Antonio M.,Camacho-Cañamón Julio,Gutiérrez Pedro Antonio,Guiote Moreno Maria Victoria,Rodríguez-Cáceres Ester,Vallejo Casas Juan Antonio,Hervás-Martínez César
Abstract
AbstractParkinson’s disease is characterised by a decrease in the density of presynaptic dopamine transporters in the striatum. Frequently, the corresponding diagnosis is performed using a qualitative analysis of the 3D-images obtained after the administration of $$^{123}$$
123
I-ioflupane, considering a binary classification problem (absence or existence of Parkinson’s disease). In this work, we propose a new methodology for classifying this kind of images in three classes depending on the level of severity of the disease in the image. To tackle this problem, we use an ordinal classifier given the natural order of the class labels. A novel strategy to perform feature selection is developed because of the large number of voxels in the image, and a method for generating synthetic images is proposed to improve the quality of the classifier. The methodology is tested on 434 studies conducted between September 2015 and January 2019, divided into three groups: 271 without alteration of the presynaptic nigrostriatal pathway, 73 with a slight alteration and 90 with severe alteration. Results confirm that the methodology improves the state-of-the-art algorithms, and that it is able to find informative voxels outside the standard regions of interest used for this problem. The differences are assessed by statistical tests which show that the proposed image ordinal classification could be considered as a decision support system in medicine.
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: A review. JAMA 323, 548–560 (2020).
2. Olanow, C. W., Stern, M. B. & Sethi, K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology 72, S1–S136 (2009).
3. Booij, J. et al. Imaging of dopamine transporters with iodine-123-fp-cit spect in healthy controls and patients with Parkinson’s disease. J. Nucl. Med. 39, 1879 (1998).
4. Son, S.-J., Kim, M. & Park, H. Imaging analysis of Parkinson’s disease patients using spect and tractography. Sci. Rep. 6, 38070 (2016).
5. Booij, J. et al. [123i] fp-cit spect shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 62, 133–140 (1997).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献